Veterinary Medicines

Carprieve 50 mg Tablets for Dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Carprieve 50 mg Tablets for Dogs
Norocarp 50 mg Tabletten für Hunde
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Manufacturing Limited
  • Norbrook Laboratories Limited
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00622
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0153/002
Concerned member states:
  • Austria

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/10/2019
Updated on: 24/04/2025
Download

Summary of Product Characteristics

English (PDF)
Published on: 16/02/2025
Download
German (PDF)
Published on: 1/02/2019
Updated on: 24/04/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 1/02/2019
Updated on: 24/04/2025
Download

Combined File of all Documents

English (PDF)
Published on: 16/02/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."